The anticarcinogenic potential of milk fat
More details
Hide details
Department of Dairy Science and Quality Management, University of Warmia and Mazury, Olsztyn, Poland
Department of Biochemistry, Faculty of Medicine, Medical University, Warsaw, Poland
Corresponding author
Marika Bielecka   

Department of Dairy Science and Quality Management, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland
Ann Agric Environ Med. 2020;27(4):512-518
Introduction and objective:
The anticarcinogenic potential of milk fat can be attributed to its antioxidant, anti-inflammatory, immunostimulatory properties as well as the presence of compounds with antimutagenic effects. In view of the high incidence of cancer the aim of this article was to review the literature concerning the biological activity of milk fat components.

Brief description of the state of knowledge:
Conjugated linoleic acid (CLA), coenzyme Q10, phospholipids, β-carotene, and vitamins A, D and E play an important role in the pro-oxidant/antioxidant homeostasis. The anti-inflammatory properties of milk fat can be attributed to the presence of phospholipids and short- and medium-chain saturated fatty acids. Conjugated linoleic acid has immunostimulatory properties, and it influences the proliferation and activity of lymphocytes and macrophages. Saturated (C10 and C12) and unsaturated (C18) fatty acids, as well as sphingolipids, exert bactericidal effects in the gastrointestinal tract. Vaccenic acid, CLA and sphingomyelin possess antimutagenic and anticarcinogenic properties. Butyric acid promotes the apoptosis of cancer cells in the liver, and delivers positive effects in the treatment of breast and colorectal cancer. Alkylglycerols activate macrophages, stimulate phagocytosis and, most importantly, the apoptosis of cancer cells.

The health benefits of milk fat are not fully exploited due to its low consumption. Therefore, only some epidemiological studies have shown a negative correlation between the consumption of high-fat dairy products and the incidence of cancer. More research is needed involving human clinical trials to allow a better understanding of the anticancer biochemistry related with milk fat compounds.

Cichosz G, Czeczot H, Bielecka M. The anticarcinogenic potential of milk fat. Ann Agric Environ Med. 2020; 27(4): 512–518. doi: 10.26444/aaem/116095
Lindmark-Månsson H, Akesson B. Antioxidative factors in milk. Br J Nutr. 2000; 84 (Suppl 1): 103–110.
Parodi PW. Anti-cancer agents in milkfat. Austr J Dairy Technol. 2003; 58(2): 114–118.
Griinari JM, Corl BA, Lacy SH, Chouinard PY, Nurmela KVV, Bauman DE. Conjugated linoleic acid is synthesized endogenously in lactating dairy cows by Δ9-desaturase. J Nutr. 2000; 130(9): 2285–2291.
Gutiérrez LF. Conjugated Linoleic Acid in milk and fermented milks: variation and effects of the technological processes. Vitae, 2016; 23(2): 134–145.
Kowalska M, Cichosz G. Dairy products – the best source of CLA. Bromat Chem Toksykol. 2013; 46(1): 1–12.
Kelley NS, Hubbard NE, Erickson KL. Conjugated linoleic acid isomers and cancer. J Nutr. 2007; 137: 2599–2607.
Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem. 2006; 17: 789–810.
Sies H, Stahl W, Sundguist AR. Antioxidant functions of vitamins. Vitamin E and C, beta-carotene and other carotenoids. Ann N.Y. Acad Sci. 1992; 669: 7–20.
van den Berg H, Faulks R, Fernando-Granado H, Hirschberg J, Olmedilla B, Sandmann G, et al. The potential for the improvement of carotenoid levels in foods and the likely systemic effects. J Sci Food Agr. 2000; 80: 880–912.
Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging. 2007; 2: 219–236.
Hosomi A, Arita M, Sato Y, Kiyose C. Affinity for α-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 1997; 409: 105–108.
Cichosz G, Czeczot H, Amroziak A, Bielecka MM. Natural antioxidants in milk and dairy products. Int J Dairy Technol. 2017; 70(2): 165–178.
Schneider C. Review: chemistry and biology of vitamin E, Mol Nutr Food Res. 2005; 49: 7–30.
Wang X, Quinn PJ. Vitamin E and its function in membrans. Prog Lipid Res. 1999; 38: 309–336.
Gohil K, Oommen S, Vasu VT, Aung HH, Cross CE. Tocopherol transfer protein deficiency modifies nuclear receptor transcriptional networks in lungs: modulation by cigarette smoke in vivo. Mol Aspects Med. 2007; 28: 435–480.
Pravst I, Zmitek K, Zmitek J. Coenzyme Q10 contents in foods and fortification strategies. Crit Rev Food Sci Nutr. 2010; 50(4): 269–280.
Overvad K, Diamant B, Holm L. Coenzyme Q 10 in health and disease, Eur J Clin Nutr. 1999; 53(10): 74–70.
Janicki B, Buzala M. Rola koenzymu Q10 w organizmie ludzi i zwierząt. Med Wet. 2012; 68(04): 214–217.
Cichosz G, Czeczot H. Milk fat – source of antioxidants in human diet. Bromat Chem Toksykol. 2011; 44(1): 8–16.
O’shea M, Bassaganya-Riera J, Mohede IC. Immunomodulatory properties of conjugated linoleic acid. Am J Clin Nutr. 2004; 79(6): 1199S-1206S.
Song HJ, Grant I, Rotondo D, Mohede I, Sattar N, Heys SD, et al. Effect of CLA supplementation on immune function in young healthy volunteers. Eur J Clin Nutr. 2005; 59: 508–517.
Belury MA. Inhibition of carcinogenesis by conjugated linoleic acid: Potential mechanisms of action. J Nutr. 2002; 132: 2995–2998.
Belury MA. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of 316 action. Ann Reviews Nut. 2002; 22(1): 505–531.
McGuire MA, McGuire MK. Conjugated linoleic acid (CLA): A ruminant fatty acid with beneficial effects on human health. J Anim Sci. 2000; 77(E-Suppl): 1–8.
Roediger WEW. The place of short-chain fatty acids in colonocyte metabolism in health and ulcerative colitis: the impraired colonocytebarrier. In: Cummings JH, Rombeau JL, Sakata T, editors Physiological and clinical aspects of short-chain fatty acids, Cambridge, Cambridge University Press. 1995. p. 337–351.
Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Advances Immunol. 2014; 121: 91–119.
Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J. 2006; 1(4): 420–439.
Rose DP; Connoly JM. Regulation of tumor aniogenesis by dietary fatty acids and eicosanoids. Nutr Cancer. 2003; 37(2): 119–127.
Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol. 2009; 54 (7): 585–594.
Krzysik M, Biernat J, Grajeta H. The Influence of Nutrients on Immune System Functioning – Part I. Immunomodulatory Effects of Fatty Acids on the Human Body. Adv Clin Exp Med. 2007; 16(1): 123–133.
Wang J, Lv S, Chen G, Gao C, He J, Zhong H, Xu Y. Meta-analysis of the association between vitamin D and autoimmune thyroid disease. Nutrients. 2015; 7(4): 2485–2498.
Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, et al. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol. 2012; 72(2): 234–240.
He D, Wang Y, Liu R, He A, Li S, Fu X, Zhou Z. 1, 25 (OH) 2D3 Activates Autophagy to Protect against Oxidative Damage of INS-1 Pancreatic Beta Cells. Biol Pharm Bull. 2019; 42(4): 561–567.
Sprong RC, Hulstein MFE, Meer van der R. Bovine milk fat components inhibit food-borne pathogens. Int Dairy J. 2002; 12: 209–215.
Snow DR, Ward RE, Olsen A, Jimenez-Flores R, Hintze KJ. Membrane-rich milk fat diet provides protection against gastrointestinal leakiness in mice treated with lipopolysaccharide. J Dairy Sci. 2011; 94: 2201–2212.
Sprong RC, Hulstein MFE, van der Meer R. Bactericidal activities of milk lipids. Antimicrob Agents Ch. 2001; 45: 1298–1301.
Wang X, Hirmo S, Willen R, Wadström T. Inhibition of Helicobacter pylori infection by bovine milk glycoconjugates in a BALB/cA mouse model. J Med Microbiol, 2001; 50, 5: 430–435.
Matsumoto M, Hara K, Kimata H, Benno Y, Shimamoto C. Exfoliation of Helicobacter pylori from gastric mucin by glycopolypeptides from buttermilk. J Dairy Sci. 2005; 88(1): 49–54.
Cichosz G, Czeczot H. Tłuszcz mlekowy w profilaktyce chorób nowotworowych. Pol Merk Lek. 2012; 33: 168–172.
Kim HK, Kim SR, Ahn JY, Cho IJ, Yoon CS, Ha TY. Dietary conjugated linoleic acid reduces lipid peroxidation by increasing oxidative stability in rats. J Nutr Sci Vitaminol. 2005; 51: 8–15.
Lee KW, Lee HJ, Chom HY, Kim YJ. Role of the conjugated linoleic acid inthe prevention of cancer. Crit Rev Food Sci Nutr. 2005; 45(2): 135–144.
Varga-Visi É, Mándoki Z, Csapó J. Increase of conjugated linoleic acid content of dairy products by adding sunfl ower oil. Acta Univ Sapientiae Aliment. 2009; 2(2): 287–293.
Białek A, Tokarz A. Dietary sources and beneficial health effects of conjugated linoleic acids (CLA). Biul. Wydz. Farm. WUM. 2009; 1: 1–12.
Blewett HJ, Gerdung CA, Ruth MR, Proctor SD, Field CJ. Vaccenic acid favourably alters immune function in obese JCR:LA-cp rats. Br J Nutr. 2009; 102(4): 526–536.
Lim JN, Oh JJ, Wang T, Lee JS, Kim SH, Kim YJ, et al. Trans-11 18:1 vaccenic acid (TVA) has a direct anti-carcinogenic effect on MCF-7 human mammary adenocarcinoma cells. Nutr. 2014; 6: 627–636.
Palozza P, Krinsky N. Beta-caroten and alpha–tocopherol are synergistic antioxidants. Arch Biochem Piophys. 1992; 15: 184–187.
Edwards BJ. Anticancer effects of Vitamin D. Am J Hematol/Oncol. 2015; 11(10): 26–33.
Xv F, Chen J, Duan L, Li S. Research progress on the anticancer effects of vitamin K2. Oncol Let. 2018; 15(6): 8926–8934.
Scott GK, Atsriku C, Kaminker P, Held J, Gibson B, Baldwin MA, et al. Vitamin K3 (menadione)-induced oncosis associated with keratin 8 phosphorylation and histone H3 arylation. Mol Pharmacol. 2005; 68(3): 606–615.
Yoshiji H, Kuriyama S, Noguchi R, Yoshii J, Ikenaka Y, Yanase K, et al. Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression. J Hepatol. 2005; 42(5): 687–693.
Yamamoto T, Nakamura H, Liu W, Cao K, Yoshikawa S, Enomoto H, et al. Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K(2). J Gastroenterol. 2009; 44(3): 228–235.
Verrax J, Taper H, Buc Calderon P. Targeting cancer cells by an oxidant-based therapy. Curr Mol Pharmacol. 2008; 1(1): 80–92.
Yoshida T, Miyazawa K, Kasuga I, Yokoyama T, Minemura K, Ustumi K, et al. Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer. Int J Oncol. 2003; 23(3): 627–632.
Nimptsch K, Rohrmann S, Linseisen J. Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin. Nutr. 2008; 87(4): 985–992.
Russell A, Laubscher A, Jimenez-Flores R, Laihom LH. Investigating the protective properties of milk phospholipids against ultraviolet light exposure in a skin equivalent model. Proc. SPIE. 2010; 75692Z-75692Z:9.
Lemonnier LA, Dillehay DL, Vespremi MJ, Abrams J, Brody E, Schmelz, EM. Sphingomyelin in the suppression of colon tumors: Prevention versus intervention. Arch Biochem Biophys. 2003; 419: 129–138.
Duan RD, Nilsson A. Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. Prog Lipid Res. 2009; 48: 62–72.
Kuchta AM, Kelly PM, Stanton C, Devery RA. Milk fat globule membrane—A source of polar lipids for colon health? A review. Int J Dairy Technol. 2012; 65: 315–333.
Vesper H, Schmelz EM, Nikolova-Karakashian MN, Dillehay DL, Lynch DV, Merrill AH. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr. 1999; 129: 1239–1250.
Küllenberg D, Taylor LA, Schneider M, Massing U. Health effects of dietary phospholipids. Lipids Health Dis. 2012; 11: 1–16.
Melvyn R, Werbach MD. Alkyloglycerols and Cancer. J Ortho Med. 1994; 9(2): 95–102.
Krotkiewski M, Przybyszewska M, Janik P. Cytostatic and cytotoxic effects of alkyloglycerols (Ecomer). Med Sci Monit. 2003; 9(11): 131–135.
Wongtangtintharn, S, Oku H, Iwasaki, H, Toda T. Effect of branched-chain fatty acids on fatty acid biosynthesis of human breast cancer cells. J Nutr Sci Vitaminol. 2004; 50: 137–143.
Yang Z, Liu S, Chen X, Chen H, Huang M, Zheng J. Induction of apoptotic cell death and in vivo growth inhibition of human cancer cells by a saturated branched-chain fatty acid, 13-methyltetradecanoic acid. Cancer Res. 2000; 60: 505–509.
Abbas S, Linseisen J, Chang-Claude J. Dietary vitamin D and calcium intake and premenopausal breast cancer risk in a German case-control study. Nutr Cancer. 2007; 59: 54–61.
Dal Maso L, Zucchetto A, Talamini R, Serraino D, Stocco CF, Vercelli M, et al. Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer. 2008; 123(9): 2188–2194.
Pala V, Krogh V, Berrino F, Sieri S, Grioni S, Tjønneland A, et al. Meat, eggs, dairy products, and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am J Clin Nutr. 2009; 90: 602–612.
Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat. 2010; 121: 469–477.
Dong JY, Zhang L, He K, Qin LQ. Dairy consumption and risk of breast cancer: a meta-analysis of prospective cohort studies. Breast Cancer Res Treat. 2011; 127(1): 23–31.
Mao QQ, Dai Y, Lin YW, Qin J, Xie LP, Zheng XY. Milk consumption and bladder cancer risk: A meta-analysis of published epidemiological studies. Nutr Cancer. 2011; 63: 1263–1271.
Keszei AP, Schouten LJ, Goldbohm RA, van den Brandt PA. Dairy intake and the risk of bladder cancer in the Netherlands Cohort Study on Diet and Cancer. Am J Epidemiol. 2010; 171: 436–446.
Holmes MD, Pollak MN, Willett WC, Hankinson SE. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev. 2002; 11: 852–861.
Wu AH, Pike MC, Stram DO. Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst. 1999; 91: 529–534.
Lee MM, Lin SS. Dietary fat and breast cancer. Ann Rev Nutr. 2000; 20: 221–248.
Alexander DD, Morimoto LM, Mink PJ, Lowe KA. Summary and meta-analysis of prospective studies of animal fat intake and breast cancer. Nutr Res Rev. 2010; 23: 169–179.
Dong JY, Zhang L, He K, Qin LQ. Dairy consumption and risk of breast cancer: a meta-analysis of prospective cohort studies. Breast Cancer Res. Treat. 2011; 127(1): 23–3.
Hjartåker A, Thoresen M, Engeset D, Lund E. Dairy consumption and calcium intake and risk of breast cancer in a prospective cohort: the Norwegian Women and Cancer study. Cancer Causes Control. 2010; 21: 1875–1885.
Knight JA, Wong J, Blackmore KM, Raboud JM, Vieth R. Vitamin D association with estradiol and progesterone in young women. Cancer Causes Control. 2010; 21: 479–483.
Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol. 2011; 51: 311–336.
Rohan TE, Negassa A, Chlebowski RT, Ceria-Ulep CD, Cochrane BB, Lane DS. A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease. Breast Cancer Res Treat. 2009; 116: 339–350.
Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. 2011; 128: 1414–1424.
Barrubés L, Babio N, Becerra-Tomás N, Rosique-Esteban N, Salas-Salvadó J. Association Between Dairy Product Consumption and Colorectal Cancer Risk in Adults: A Systematic Review and Meta-Analysis of Epidemiologic Studies. Adv Nutr. 2018; 10(suppl_2): 190–211.
Chen L, Li M, Li H. Milk and yogurt intake and breast cancer risk: A meta-analysis. Medicine 2019; 98(12): e14900.
Steck SE, Omofuma OO, Su LJ, Maise AA, Woloszynska-Read A, Johnson CJ, Zhang H, et al. Calcium, magnesium, and whole-milk intakes and high-aggressive prostate cancer in the North Carolina–Louisiana Prostate Cancer Project (PCaP). Am J Clin Nutr. 2018; 107, 5: 799–807.
López-Plaza B, Bermejo LM, Santurino C, Cavero-Redondo I, Álvarez-Bueno C, Gómez-Candela C. Milk and Dairy Product Consumption and Prostate Cancer Risk and Mortality: An Overview of Systematic Reviews and Meta-analyses. Adv Nutr. 2019; 10(suppl_2): S212-S223.
Bannerman DD. Pathogen-dependent induction of cytokines and other soluble inflammatory mediators during intramammary infection of dairy cows. J Anim Sci. 2009; 87(suppl_13): 10–25.
Collier RJ, Miller MA, McLaughlin CL, Johnson HD, Baile CA. Effects of recombinant bovine somatotropin (rbST) and season on plasma and milk insulin-like growth factors I (IGF-I) and II (IGF-II) in lactating dairy cows. Domest Anim Endocrin. 2008; 35(1): 16–23.
Christopoulos PF, Msaouel P, Koutsilieris M. The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer. 2015; 14(1): 43.
Harrison S, Lennon R, Holly J, Higgins JP, Gardner M, Perks C. et al. Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis. Cancer Causes Control. 2017; 28(6): 497–5.
Moss MO. Risk assessment for aflatoxins in foodstuffs. Int. Biodeterior Biodegrd. 2002; 50: 137–142.
Parodi PW. Impact of cows’ milk estrogen on cancer risk. Int Dairy J. 2012; 22: 3–14.
Moorman PG, Terry PD. Consumption of dairy products and the risk of breast cancer: a review of the literature. Am J Clin Nutr. 2004; 80: 5–14.
Qin LQ, Wang PY, Kaneko T, Hoshi K, Sato A. Estrogen: one of the risk factors in milk for prostate cancer. Med Hypotheses. 2004; 62: 133–142.
Vlaeminck B, Fievez V, Cabrita ARJ, Fonseca AJM, Dewhurst RJ. Factors affecting odd- and branched-chain fatty acids in milk: A review. Anim Feed Sci Technol. 2006; 131: 389–417.
Krzyżewski J, Strzalkowska N, Bagnicka E, Jozwik A, Horbanczuk JO. Effects of Antioxidants in Fat Contained in Bulky Forages on Cows’ Milk Quality. Żywn. Nauk, Technol Jakość. 2012; 19: 35–45.
Journals System - logo
Scroll to top